ACCESS Newswire

Envista

16.5.2024 15:32:20 CEST | ACCESS Newswire | Press release

Share
DEXIS Innovation Continues With New DEXIS Ti2 Sensor as Successor to the DEXIS Titanium Sensor, the #1 Selling Intraoral Sensor in the United States

QUAKERTOWN, PA / ACCESSWIRE / May 16, 2024 / Today, DEXIS launches the latest innovation in its digital ecosystem with an all-new dental intraoral sensor, the DEXIS™ Ti2 Sensor. The DEXIS digital ecosystem is a comprehensive, AI-powered platform for dental imaging, designed to connect and streamline digital workflows for enhanced productivity.

To view this piece of content from cdn.nwe.io, please give your consent at the top of this page.
DEXIS Ti2 Sensor
DEXIS Ti2 Sensor

The Ti2 sensor builds on the success of its predecessor, the DEXIS™ Titanium Sensor, the #1 digital intraoral sensor in the United States.* In 2023, DEXIS sensors processed over 167 million images, making it a top choice for intraoral sensors and scanners, as well as x-ray and CBCT technology worldwide.

Bringing several new features to the DEXIS 2D imaging portfolio, the Ti2 sensor includes:

  • A housing design that's twice as durable as previous generations
  • A proactive servicing module
  • Access to 2D AI Dental Findings that automatically detect up to six types of dental findings on 2D radiographs

With DEXIS, 2D AI Dental Findings are integrated into both DTX Studio™ Clinic and DEXIS Imaging Suite software-not a separate third-party application. 2D AI Dental Findings automatically identifies periapical radiolucency, bone loss, calculus, caries, discrepancy at margin of existing restoration, and root canal filling deficiency.

"For patients with periodontal disease, we have identified sub-gingival calculus and monitored their bone levels. Caries detection and diagnosis is clear and precise with the contrast available with these images," said Dr. Moe Katz of Katz & Pfeffer Dental Studio.

The Ti2 sensor housing is twice as durable and two times as drop-resistant as the Titanium Sensor. The new posterior holder and WiseAngle™ cable design reduce stress on the sensor/cable connection, further strengthening the Ti2 sensor.

DEXIS also focuses on maximizing the productivity of the dental practice with the newly launched DEXIS Connect Pro. The solution proactively monitors the health of the DEXIS family of sensors through IoT technology and automatically arranges support or equipment replacements if performance issues are ever detected.

"DEXIS Connect Pro provides the kind of customer experience I've come to expect from DEXIS," says Amber Metro-Sanchez, dental hygienist at Omni Dental. "The knowledge that my sensor communicates with DEXIS support and that they're ready to help me if I ever need it gives me peace of mind. They've always been so responsive and helpful, DEXIS Connect Pro demonstrates the kind of attention to customer care and continuous innovation I've grown accustomed to with DEXIS."

Through the use of CleanCapture™ technology, the Ti2 sensor captures high-resolution images by reducing noise and enhancing anatomical detail. The technology allows the sensor to be flexible and ready to adapt to varying exposure levels, generator usage, or positioning techniques to capture clear, accurate images reliably - even in challenging circumstances.

Equipped with its PerfectSize™ design, the Ti2 sensor is engineered to fit every patient comfortably, making it a convenient, one-size-fits-all solution for busy practices.

Experience the new DEXIS Ti2 Sensor at booth 1665 at CDA South on May 16-18, 2024.

*DEXIS Titanium Sensor- December 2023 SDM US Market Share Data.

About DEXIS 

DEXIS has been a global leading brand in digital radiography for 70+ years. Today, DEXIS has brought together the most trusted brands in 3D imaging, intraoral scanning solutions, and diagnostic software to provide patients with a complete digital diagnostic solution under a brand name. Our innovative award-winning technology enhances how the patient is diagnosed, accelerates the workflow, and delivers simple treatment paths with better patient outcomes. For more information, please visit https://www.dexis.com.

Contact Information:

Hayley Reed
Regional Marketing Director, DEXIS IOS
hayley.reed@envistaco.com
(714) 628-8533

SOURCE: DEXIS

To view this piece of content from stats.nwe.io, please give your consent at the top of this page.

View the original press release on newswire.com.

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.

About ACCESS Newswire

DK

Subscribe to releases from ACCESS Newswire

Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from ACCESS Newswire

Digi Power X Reports Q3 2026 Revenue Up 85% and AI Revenue Up Over 400% Compared to Q213.11.2026 13:30:00 CET | Press release

MIAMI, FL / ACCESS Newswire / November 13, 2026 / Digi Power X Inc. (Nasdaq:DGXX)(Cboe Canada:DGX) ("Digi Power X" or the "Company"), an AI data center infrastructure operator, today reported its financial and operating results for the third quarter ended September 30, 2026 (all amounts in U.S. dollars, unless otherwise indicated). The Company's quarterly report on Form 10-Q, which includes unaudited consolidated financial statements and management's discussion and analysis ("MD&A") for the quarter ended September 30, 2026, is being filed and made accessible under the Company's continuous disclosure profile on SEDAR+ at www.sedarplus.ca and will also be available on EDGAR at www.sec.gov/edgar. Third Quarter 2026 Highlights All amounts in U.S. dollars (millions) Revenue of $12.25 million, up 85% from the previously completed fiscal quarter and an increase of 50% compared to the quarter ended September 30, 2025; $119.6 million in cash, cash equivalents and digital currencies, $103.0 mill

Fermi Announces New Agreements with Investment-Grade Hyperscaler and Third Quarter 2026 Financial Results12.11.2026 13:00:00 CET | Press release

DALLAS, TX / ACCESS Newswire / November 12, 2026 / Fermi Inc. (NASDAQ:FRMI)(LSE:FRMI), operating as Fermi America™ ("Fermi" or the "Company"), today announced its third quarter 2026 financial results and multiple new agreements with an investment-grade hyperscaler to advance 600 megawatts ("MW") of power capacity at Project Matador. A conference call is scheduled for 9 a.m. Eastern Time / 2 p.m. British Time today, November 12, 2026. Accompanying slides and prepared remarks can be found at https://investor.fermiamerica.com. Participation details are included in this release. "Hyperscalers want sites that are ready with permitted power, and Fermi's Project Matador is one of few that can meet that demand today," said Lee McIntire, Fermi Chief Executive Officer. "Our headstart in speed to power is a key reason an investment-grade hyperscaler has signed up for 600 megawatts and committed more than $200 million up front to accelerate construction at Project Matador with an additional $90 mi

Nexteer Announces First Share Repurchase Programme of Up to US$60 Million12.11.2026 01:40:00 CET | Press release

HONG KONG, HK / ACCESS Newswire / November 11, 2026 / Nexteer Automotive today announced that its Board of Directors has approved, the Company's first share repurchase programme of up to US$60 million, equivalent to approximately HK$471 million. The programme reflects the Board's confidence in Nexteer's business and long-term prospects. The Group's strong liquidity position supports returning capital to shareholders while continuing to invest in the business and its future development. Disciplined Capital Allocation The programme complements Nexteer's dividend distributions and represents a further step in returning capital to shareholders. It follows the dividend paid out in July 2026 of approximately US$46 million, representing 45% of the Company's net income attributable to shareholders for the year ending December 31, 2025 -and the highest dividend payout ratio in the Company's history. Nexteer remains committed to disciplined capital allocation, balancing investment in the busines

GoodData.AI Launches the Agentic Serving Plane, a New Category of Enterprise Data Infrastructure for AI Agents10.11.2026 15:30:00 CET | Press release

SAN FRANCISCO, CA / ACCESS Newswire / November 10, 2026 / GoodData.AI, the open agentic analytics platform, today launched the Agentic Serving Plane, a governed execution layer designed for the high-concurrency, context-rich data workloads created by AI agents. The Agentic Serving Plane sits between enterprise data platforms and the applications, analytics experiences and agents that consume them. It provides workload serving, business semantics, contextual grounding, access control, and AI execution services through a common governed layer. The current enterprise data infrastructure was designed primarily for humans: occasional queries, predictable workloads, and access by known users. AI agents operate differently. A single business task can generate tens or hundreds of short-lived data operations as an agent investigates, reasons, and decides what to ask next. When many agents operate simultaneously, intermittent human querying becomes continuous, high-concurrency agentic demand. Ag

Envision Pharma Group appoints Leigh Anne Siino as Senior Vice President of Commercial, Two Labs and Riparian10.11.2026 15:00:00 CET | Press release

FAIRFIELD, CT / ACCESS Newswire / November 10, 2026 / Envision Pharma Group (Envision), a global, technology-enabled solutions partner to the life sciences industry, has appointed Leigh Anne Siino as Senior Vice President of Commercial, Two Labs and Riparian. Siino will lead a team providing best-in-class launch and revenue management services to the biopharma community. Pharma and biotech companies across the industry seek suppliers who can support them from their earliest stages, often before they have built in-house commercial, market access, and revenue management capabilities. Two Labs provides commercialization services and consulting support as these companies prepare for and execute successful launches; Riparian offers consulting, managed services, and technology to manage and protect revenue as their therapies reach patients. Together, Envision's Two Labs and Riparian businesses offer a single, connected solution spanning launch and beyond. Under Siino's leadership, clients wi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye